QID 174817

QID 174817: SUSE Enterprise Linux Security update for the Linux Kernel (Live Patch 8 for SLE 15 SP2) (SUSE-SU-2021:0841-1)

This update for the Linux Kernel 5.3.18-24_43 fixes several issues.

The following security issues were fixed:

- CVE-2020-29368: Fixed an issue in copy-on-write implementation which
could have granted unintended write access because of a race condition
in a THP mapcount check (bsc#1179664).
- CVE-2021-3347: Fixed a use-after-free in the PI futexes during fault
handling, allowing local users to execute code in the kernel
(bsc#1181553).
- CVE-2020-28374: Fixed insufficient identifier checking in the LIO SCSI
target code which could have been used by remote attackers to read or
write files via directory traversal in an XCOPY request (bsc#1178684).

Successful exploitation allows attacker to compromise the system.

  • CVSS V3 rated as Critical - 8.1 severity.
  • CVSS V2 rated as High - 7.2 severity.
    • Solution
    Upgrade to the latest package which contains the patch. To install this SUSE Security, Update use YaST online_update. Alternatively you can run the command listed for your product. To install packages using the command line interface, use command "yum update". Refer to Suse security advisory: SUSE-SU-2021:0841-1 to address this issue and obtain further details.
    Vendor References

    CVEs related to QID 174817

    CVE-2020-29368 | CVE-2020-28374 | CVE-2021-3347 |
    Software Advisories
    Advisory ID Software Component Link
    SUSE-SU-2021:0841-1 SUSE Enterprise Linux URL Logo lists.suse.com/pipermail/sle-security-updates/2021-March/008510.html
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].